Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Search help

61 results

  1. Endometrial Cancer Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65829
    ... not affect overall survival (OS). A three-drug regimen of doxorubicin, cisplatin, and paclitaxel with granulocyte-colony stimulating factor (G-CSF) was ...
  2. Breast Cancer Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65744
    ... receive chemotherapy with or without atezolizumab. The chemotherapy regimen included paclitaxel and cyclophosphamide with doxorubicin or epirubicin. The primary end point was IDFS. ...
  3. Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancer Treatment (PDQ®) - PDQ Cancer Information Summaries - ... 
    https://www.ncbi.nlm.nih.gov/books/NBK66007
    ... to the standard regimen, carboplatin plus pegylated liposomal doxorubicin is an important option for patients with platinum-sensitive recurrence. Carboplatin plus paclitaxel has been considered the standard regimen for platinum-sensitive recurrence in the absence of ...
  4. NLM Digital Collections - Poly ADP-ribose polymerase (PARP) inhibitors for ovarian cancer : effectiveness and value : ... 
    Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, September 28, 2017
    resource.nlm.nih.gov/101723925
    ... taxane agent (e.g., paclitaxel, docetaxel) or liposomal doxorubicin.7-9 For recurrence, several chemotherapy regimens (e.g., docetaxel, paclitaxel, gemcitabine, liposomal doxorubicin, topotecan and etoposide) may be ...
  5. Gastric Cancer Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65766
    ... with either epirubicin and cisplatin, etoposide and leucovorin, doxorubicin and methotrexate, leucovorin and irinotecan, or docetaxel and cisplatin or oxaliplatin.[ 3 - 9 ] Doublet regimens. A taxane (docetaxel or paclitaxel) and either cisplatin or carboplatin. 5-FU and ...
  6. Managing locally advanced or metastatic bladder cancer - Bladder Cancer - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK356301
    ... PubMed : 22897883 ] Han KS, et al. Methotrexate, vinblastine, ... et al. Combination of gemcitabine and paclitaxel is a favorable option for patients with advanced ...
  7. Bladder Cancer Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65962
    ... and vinblastine; carboplatin, epirubicin, methotrexate, and vinblastine; and ... the MVAC regimen demonstrated improved response rate and longer median survival ( ...
  8. NLM Digital Collections - Management of epithelial ovarian cancer : a national clinical guideline 
    Publication: Edinburgh, Scotland : Scottish Intercollegiate Guidelines Network (SIGN), 2013
    resource.nlm.nih.gov/101671098
    ... cancer what is the optimal chemotherapy 6.3 regimen? Consider: platinum (carboplatin), taxanes (paclitaxel), topotecan, bevacizumab, gemcitabine, trabectedin, pegylated liposomal doxorubicin; consider mono and combination therapies (eg single agent ...
  9. Managing locally advanced or metastatic bladder cancer - Bladder Cancer - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK356292
    ... incurable locally advanced or metastatic bladder cancer? Comparison: Paclitaxel & ... for second-line chemotherapy (more...) Table ...
  10. Thymoma and Thymic Carcinoma Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK66041
    ... modality for patients with inoperable thymic carcinoma. Most regimens used are similar to those used to treat thymoma and ... (chemotherapy): A phase II ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · next · last